ライフサイエンスコーパス: pulse oximetry

1 and clinical application of multiwavelength pulse oximetry.

2 rly labor to either "open" or "masked" fetal pulse oximetry.

3 oke, with transcranial doppler and overnight pulse oximetry.

4 its impact on PPG based applications such as pulse oximetry.

5 ed on arterial blood gas but not detected by pulse oximetry.

6 of consolidation by imaging and hypoxemia by pulse oximetry.

7 were similar with intermittent vs continuous pulse oximetry.

8 ors respiratory status as assessed by reflex pulse oximetry.

9 e-/sex-matched controls undergoing overnight pulse oximetry.

10 maging, arterial blood gas measurements, and pulse oximetry.

11 potentially detectable through screening via pulse oximetry.

12 Test if a novel panel consisting of pulse oximetry, 12-lead electrocardiography, and serum t

13 The most frequent interventions-pulse oximetry (66.5%), other monitoring (59.6%), and su

14 +/- 1.9; p<0.001), as was use of continuous pulse oximetry (78% vs. 58%, respectively; p=0.001).

15 0 mm Hg; or oxygen saturation as measured by pulse oximetry, 91-94%) or high-oxygenation (Pa(O(2)), 1

16 0 mm Hg; or oxygen saturation as measured by pulse oximetry, 96-100%) target until ICU discharge or 2

17 tion and favourable cost-effectiveness makes pulse oximetry a promising candidate for improving the p

18 Pulse oximetry, a relatively inexpensive technology, has

19 here remain major challenges to implementing pulse oximetry-a cheap, decades old technology-into rout

20 Rationale: Pulse oximetry accuracy varies across races, underscorin

21 udy suggest that racial and ethnic biases in pulse oximetry accuracy were associated with greater occ

22 peripheral oxygen saturation as measured by pulse oximetry (adjusted MD at 5 minutes, 15.3 percentag

23 nd staff from 14 Kenyan hospitals to examine pulse oximetry adoption.

24 eep apnea using questionnaire plus nocturnal pulse oximetry against using polysomnography to identify

25 One-third of pulse oximetry alarm notifications were for clinically r

26 aceted oxygen system compared to introducing pulse oximetry alone.

27 he accuracy of oxygen saturation measured by pulse oximetry among Black and White pediatric patients.

28 Documents also agreed on the routine use of pulse oximetry and blood pressure monitoring during endo

29 Cardiac monitoring, pulse oximetry and capnography are used, often without s

30 hospital admission, particularly the use of pulse oximetry and chest radiography.

31 spital inpatient records to explore roles of pulse oximetry and clinical guidelines on hospital atten

32 y survey and retrospective clinical audit of pulse oximetry and medical oxygen availability and use i

33 We aimed to evaluate availability and use of pulse oximetry and medical oxygen in seven LMICs in Asia

34 Pulse oximetry and oxygen are complementary cost-effecti

35 We found that availability and use of pulse oximetry and oxygen in these seven LMICS (which ha

36 trategies and programmes, and integration of pulse oximetry and oxygen into clinical guidelines, serv

37 act, cost, and cost-effectiveness of routine pulse oximetry and oxygen on ALRI outcomes at scale rema

38 impact and cost-effectiveness of scaling up pulse oximetry and oxygen on childhood ALRI outcomes in

39 ated by publications addressing knowledge of pulse oximetry and those warning against the use of tran

40 ts suspected of bacterial pneumonia, bedside pulse oximetry and urinary antigen testing for Streptoco

41 ed heart and respiratory rate) and WristOx2 (pulse-oximetry and derived pulse rate) sensors.

42 ount for interaction between SpO2 threshold (pulse oximetry) and clinical guidelines, clustering by c

43 rate (electrocardiogram), oxygen saturation (pulse oximetry), and brachial artery blood flow and shea

44 t-level and hospital-level use of continuous pulse oximetry, and (2) real-time 1:1 feedback to clinic

45 ected, and standard vital signs (heart rate, pulse oximetry, and body temperature) were monitored at

46 O(2) is the oxygen saturation as measured by pulse oximetry, and DLCO is the diffusing capacity for c

47 ry artery pressure, central venous pressure, pulse oximetry, and end-tidal CO(2) were continuously mo

48 hild was monitored with electrocardiography, pulse oximetry, and invasive blood pressure via femoral

49 rate, lower Glasgow Coma Scale score, lower pulse oximetry, and nursing home residence during out-of

50 x, mean arterial blood pressure, heart rate, pulse oximetry, and transcutaneous oxygen and carbon dio

51 Simultaneous blood gas, pulse oximetry, and ventilator settings were collected.

52 Nadir oxygen saturation as measured by pulse oximetry, apnea-hypopnea index, and the fraction o

53 naccuracies in oxygen saturation measured by pulse oximetry are present in patients with COVID-19 and

54 gression to assess the impact of introducing pulse oximetry as a prognostic tool to distinguish sever

55 We assessed the performance of pulse oximetry as a screening method for the detection o

56 The concept of using pulse oximetry as a screening method to detect undiagnos

57 We prospectively assessed the accuracy of pulse oximetry as a screening test for congenital heart

58 stringent BPD definition based on systematic pulse oximetry assessment at 36 weeks' postmenstrual age

59 ist, including the introduction of universal pulse oximetry at a hospital in Chisinau, Moldova, where

60 rgical safety checklist and the provision of pulse oximetry at a referral hospital in Moldova, a lowe

61 The proportion of neonates and children with pulse oximetry at admission increased from 2365 (23.7%)

62 d age on control of breathing, inaccuracy of pulse oximetry at low oxygen saturations, and temperatur

63 h leading to the development of new types of pulse oximetry-based monitoring techniques.

64 Methods: PWADs were derived from pulse oximetry-based photoplethysmography signals in thr

65 ies (gestation >34 weeks) were screened with pulse oximetry before discharge.

66 We also sought risk factors for pulse oximetry below 90%.

67 rch in recent years to expand the utility of pulse oximetry beyond the simple measurement of arterial

68 cords that include prompts, the promotion of pulse oximetry by senior doctors, and monitoring and fee

69 Pulse oximetry can be used reliably to estimate the arte

70 Pulse oximetry can significantly increase the incidence

71 ng capacity of the lung for carbon monoxide, pulse oximetry, chest radiograph, and high-resolution th

72 ed examination of the pulmonary circulation, pulse oximetry, complete blood count, and serum chemistr

73 were similar for intermittent and continuous pulse oximetry considering societal and health care pers

74 Pulse oximetry correlates well with cooximeter-measured

75 Our findings suggest that pulse oximetry could be beneficial in supplementing clin

76 Expanding pulse oximetry coverage to all facilities reduced travel

77 s on day 1 of health-facility admission (ie, pulse oximetry coverage).

78 Pulse oximetry data from 54 countries suggested that aro

79 h hypoxemia were quantified using continuous pulse oximetry data that had been sampled every 10 secon

80 ed greater likelihood of a patient receiving pulse oximetry during the post-intervention period compa

81 with hepatopulmonary syndrome underwent home pulse-oximetry during sleep.

82 P, arterial hemoglobin oxygen saturation (by pulse oximetry), end-tidal PCO2, and carotid artery bloo

83 ed their readiness and reported that all had pulse oximetry equipment onsite and 74.4% had access to

84 lighted critical limitations in conventional pulse oximetry, especially in diverse populations.

85 gas-derived oxygen saturation < 88% despite pulse oximetry-estimated oxygen saturation >= 92%), and

86 Pulse oximetry-estimated oxygen saturation on average ov

87 ight-thousand two-hundred eighty-five paired pulse oximetry-estimated oxygen saturation-arterial bloo

88 E)), end-tidal carbon dioxide ( PETCO2 ) and pulse oximetry estimation of oxygen saturation ( SpO2 ),

89 algorithm using questionnaire and nocturnal pulse oximetry excluded few patients from sleep studies,

90 .99), lower oxygen saturation as measured by pulse oximetry/Fi(O(2)) before induction (OR, 0.998; 95%

91 the index, oxygen saturation as measured by pulse oximetry/Fi(O(2)) had a greater weight than respir

92 he ratio of oxygen saturation as measured by pulse oximetry/Fi(O(2)) to respiratory rate) for determi

93 tcome was the sensitivity and specificity of pulse oximetry for detection of critical congenital hear

94 The overall sensitivity of pulse oximetry for detection of critical congenital hear

95 We assessed the screening characteristics of pulse oximetry for HPS.

96 lected studies that assessed the accuracy of pulse oximetry for the detection of critical congenital

97 effectiveness of intermittent vs continuous pulse oximetry found similar length of hospital stay and

98 as reduced oxygen saturation as measured by pulse oximetry/fraction of inspired oxygen (FiO(2)) and

99 r) + (nadir oxygen saturation as measured by pulse oximetry >82.5%) + (Fhypopneas >58.3%).

100 Pulse oximetry guides clinical decisions, yet does not u

101 Pulse oximetry guides triage and therapy decisions for C

102 Routine use of pulse oximetry has been associated with changes in bronc

103 Reliance on pulse oximetry has been associated with increased hospit

104 hat, assuming access to supplemental oxygen, pulse oximetry has the potential to avert up to 148,000

105 Experimental sensors based on reflectance pulse oximetry have been developed for use in internal s

106 Recent advances in pulse oximetry have made it possible to noninvasively me

107 Pulse oximetry identified fatal pneumonia episodes at HC

108 analyses suggested that the introduction of pulse oximetry improved oxygen practices prior to implem

109 e home-based monitoring using spirometry and pulse oximetry in adults with asthma, bronchiectasis/cys

110 s for future research of home spirometry and pulse oximetry in asthma, bronchiectasis/cystic fibrosis

111 rements for universal CCHD screening through pulse oximetry in birth hospitals.

112 ebite, oxygen administration, and the use of pulse oximetry in first aid, with the inclusion of pedia

113 ed using clinical guidelines with or without pulse oximetry in Malawi.

114 ow nasal oxygen, the expansion of the use of pulse oximetry in place of arterial blood gases, the use

115 e measured by a clinical severity score, and pulse oximetry in room air was done.

116 ngs support the standard use of intermittent pulse oximetry in stable infants hospitalized with bronc

117 To assess the accuracy of pulse oximetry in the diagnosis of hypoxemia in SCD, we

118 et standard targets for oxygen saturation by pulse oximetry in the first 10 minutes or for clinical n

119 s with diabetic ketoacidosis and, along with pulse oximetry, in lung-function laboratories to estimat

120 upport front-line health-care workers to use pulse oximetry, including rethinking traditional binary

121 be effective, including the introduction of pulse oximetry into routine hospital care and clinical a

122 the baseline period (enabling evaluation of pulse oximetry introduction) and evaluated mortality and

123 three study periods: baseline (usual care), pulse oximetry introduction, and stepped introduction of

124 2)) 315 (if oxygen saturation as measured by pulse oximetry is 97%) to identify hypoxemia; 3) retain

125 Pulse oximetry is a noninvasive technology that is integ

126 Pulse oximetry is a safe, feasible test that adds value

127 Pulse oximetry is a ubiquitous non-invasive medical sens

128 Routine screening for CCHD using pulse oximetry is being increasingly supported and was a

129 INTERPRETATION: Pulse oximetry is highly specific for detection of criti

130 Given pulse oximetry is increasingly substituting for arterial

131 Conclusion: Pulse oximetry is not sufficiently sensitive to screen f

132 ing for hepatopulmonary syndrome (HPS) using pulse oximetry is recommended in liver transplant (LT) c

133 Pulse oximetry is ubiquitous but detailed understanding

134 Along with pulse oximetry, it has reduced anesthesia-related morbid

135 Vital signs, pulse oximetry, laser Doppler flowmetry, and toe tempera

136 tudy, overestimation of oxygen saturation by pulse oximetry led to delayed delivery of COVID-19 thera

137 The only independent predictors of pulse oximetry less than 90% were baseline pulse oximetr

138 oxemia with oxygen saturation as measured by pulse oximetry <80% was the major physiologic predictor

139 tomic Fontan obstruction, clinical cyanosis (pulse oximetry <90%), polycythemia, portal variceal dise

140 oxemia with oxygen saturation as measured by pulse oximetry <90%.

141 Hg, pulse >=110 bpm, or peripheral cutaneous pulse oximetry <=92%), prediagnosis anticoagulant use, o

142 Where some oxygen is available, pulse oximetry may improve oxygen usage and clinical out

143 cility and ward levels, including documented pulse oximetry measurement on admission, documented oxyg

144 Pulse oximetry measurements on admission were documented

145 intermittent pulse oximetry monitoring (ie, pulse oximetry measurements were obtained along with a s

146 Pulse oximetry measurements with true saturation values

147 signed to undergo continuous or intermittent pulse oximetry monitoring (ie, pulse oximetry measuremen

148 Our results suggest that intermittent pulse oximetry monitoring can be routinely considered in

149 guidelines discourage the use of continuous pulse oximetry monitoring in hospitalized children with

150 Continuous pulse oximetry monitoring is recommended to improve safe

151 Intermittent pulse oximetry monitoring of nonhypoxemic patients with

152 mean length of stay did not differ based on pulse oximetry monitoring strategy (48.9 hours [95% CI,

153 The overall continuous pulse oximetry monitoring use percentage in these patien

154 0% reported routine use of blood pressure or pulse oximetry monitoring, and 75% reported daily rounds

155 Side effects were monitored by pulse oximetry, nasal end-tidal capnography, and serial

156 ve regression model was used to estimate the pulse oximetry need for countries that did not provide d

157 outpatient clinics lack capacity to conduct pulse oximetry, nutritional assessment, or HIV testing,

158 f pulse oximetry less than 90% were baseline pulse oximetry (odds ratio, 0.71; 95% CI, 0.64-0.79; p <

159 e, with a blood pressure of 160/72 mm Hg and pulse oximetry of 93% on 6 L/min oxygen therapy through

160 e, with a blood pressure of 160/72 mm Hg and pulse oximetry of 93% on 6 L/min oxygen therapy through

161 d mild systemic hypoxia (85 % O2 saturation; pulse oximetry of the earlobe).

162 We model 15 scenarios ranging from no pulse oximetry or oxygen (null scenario) to high coverag

163 There were no differences in laser Doppler, pulse oximetry, or toe temperature measurements during o

164 air oxygen saturation of 85% as measured by pulse oximetry, or use of mechanical ventilation).

165 thnicity [10.4%], and 10 133 White [41.4%]), pulse oximetry overestimated SaO2 for Black (adjusted me

166 ge requiring supplemental oxygen to maintain pulse oximetry oxygen saturation of 95% or higher.

167 ion of admitted neonates and children with a pulse oximetry oxygen saturation reading documented in t

168 hma Score, respiratory rate, heart rate, and pulse oximetry oxygen saturation values were recorded at

169 Score II severity score (p = 0.03), baseline pulse oximetry (p < 0.001), baseline PaO2/FIO2 ratio (p

170 .001), metered dose inhalers (p = .01), and pulse oximetry (p = .02).

171 ompared the full oxygen system period to the pulse oximetry period and evaluated odds of death for ch

172 Compared to the pulse oximetry period, the full oxygen system had no ass

173 OM), wearable photoplethysmography (WD), and pulse oximetry (PO) during baseline, ischemia, and reper

174 ment Surfactant Positive Airway Pressure and Pulse Oximetry Randomized Trial Neuroimaging and Neurode

175 Analyses were done on all babies for whom a pulse oximetry reading was obtained.

176 iolitis, those with an artificially elevated pulse oximetry reading were less likely to be hospitaliz

177 only obtaining intermittent or "spot check" pulse oximetry readings for those who show clinical impr

178 cal signs and symptoms, admission diagnoses, pulse oximetry readings, oxygen therapy details, and fin

179 Data collected included all preoperative pulse oximetry recordings, all values from preoperative

180 cially weak areas in ICU monitoring, such as pulse oximetry reliability.

181 o; and (3) usually, an associated decline in pulse oximetry saturation.

182 f the 188 high-risk cases, 94 (50.0%) passed pulse oximetry screening and 36 (19.1%) were initially d

183 nates: access to postdischarge newborn care, pulse oximetry screening for congenital heart disease, a

184 Pulse oximetry screening for cyanotic congenital heart d

185 rity of clinicians felt the case for routine pulse oximetry screening had not been proven.

186 Pulse oximetry screening is a highly specific, moderatel

187 Pulse oximetry screening should be routine and performed

188 udies reporting the test accuracy of routine pulse oximetry screening, and involving over 150 ,000 ba

189 reviews the development of novel reflectance pulse oximetry sensors for the esophagus and bowel, and

190 The use of novel reflectance pulse oximetry sensors has been successfully demonstrate

191 Pulse oximetry showed oxygen desaturations below 90% in

192 Pulse oximetry significantly underestimates true arteria

193 Pulse oximetry slightly overestimated oxyhemoglobin perc

194 00 mm Hg or oxygen saturation as measured by pulse oximetry Sp(O(2)):Fi(O(2)) 315 (if oxygen saturati

195 according to peripheral oxygen saturation by pulse oximetry (Sp o2 )/F io2 ratio compared with Pa o2

196 to achieve oxygen saturation as measured by pulse oximetry (Sp(O(2))) that decreased from 95% to 86%

197 tocolized assessment of oxygen saturation by pulse oximetry (SpO(2) ), arterial blood gas, spirometry

198 target for oxygen saturation as measured by pulse oximetry (Spo(2)) (90%; goal range, 88 to 92%), an

199 oxygen saturation (SaO(2)) of <88% despite a pulse oximetry (SpO(2)) reading of >=92%), and whether r

200 r limit for oxygen saturation as measured by pulse oximetry (Spo(2)) was 90%.

201 ygen saturation of hemoglobin as measured by pulse oximetry (Spo(2)) were monitored continuously thro

202 readings of arterial blood gas (SaO(2)) and pulse oximetry (SpO(2)) were obtained, black patients ha

203 %; exercise oxygen saturation as measured by pulse oximetry [Spo(2)] = 86.5 +/- 2.9%) participated.

204 o 70 mm Hg; oxygen saturation as measured by pulse oximetry [Spo(2)], 88 to 92%) or liberal oxygen th

205 ion levels in arterial blood, SaO(2), and by pulse oximetry, SpO(2)).

206 symptom score, multi-slice CT, perfusion CT, pulse oximetry (SpO2%), and hemoglobin concentration (Hb

207 In this study, blood oxygen saturation using pulse oximetry (SpO2) and pulse rate were measured daily

208 quest, when oxygen saturation as measured by pulse oximetry (SpO2) dropped to less than 84%, or after

209 Pulse oximetry (SpO2) is routinely used for transcutaneo

210 the time to oxygen saturation as measured by pulse oximetry (Spo2) less than 80% (event) during 35 mi

211 with target oxygen saturation as measured by pulse oximetry (SpO2) of 88-92% (n = 52) or a liberal ox

212 hemoglobin oxygen saturation as measured by pulse oximetry (SpO2) to fraction of inspired oxygen (Fi

213 ation levels in arterial blood (SaO2) and by pulse oximetry (SpO2).

214 n saturation (arterial [SaO2] or measured by pulse oximetry [SpO2]) </= 90%.

215 ion (oxyhemoglobin saturation as measured by pulse oximetry [Spo2], 89 to 93%).

216 respiratory rate [RR], oxygen saturation by pulse oximetry [Spo2], mean arterial pressure [MAP]) was

217 rt monitoring, advances in intrapartum fetal pulse oximetry, thresholds of acidosis associated with f

218 t-effective strategy is the full scale-up of pulse oximetry to 90% usage rate and oxygen to 80% avail

219 r estimating cardiac output; b) the standard pulse oximetry to screen for pulmonary problems; c) tran

220 xic gas to titrate arterial O(2) saturation (pulse oximetry) to 80%, while remaining normocapnic via

221 h ancillary tests (such as chest imaging and pulse oximetry) to improve pneumonia identification; sec

222 The cardiac index, pulse oximetry, transcutaneous oxygen tension, transcuta

223 oxygen (null scenario) to high coverage (90% pulse oximetry usage and 80% oxygen availability) across

224 rategies for guideline-discordant continuous pulse oximetry use among hospitalized children with bron

225 acteristics, guideline-discordant continuous pulse oximetry use decreased from 53% (95% CI, 49%-57%)

226 The mortality impact of pulse oximetry use during infant and childhood pneumonia

227 onal guidelines recommend against continuous pulse oximetry use for hospitalized children with bronch

228 ite) during a 3.5-month period of continuous pulse oximetry use in children with bronchiolitis not re

229 Measure continuous pulse oximetry use in children with bronchiolitis.

230 Guideline-discordant continuous pulse oximetry use in hospitalized children was measured

231 Continuous pulse oximetry use percentages were risk standardized us

232 Hospital-level unadjusted continuous pulse oximetry use ranged from 2% to 92%.

233 nicians when guideline-discordant continuous pulse oximetry use was discovered during in-person data

234 Intermittent (every 4 hours) vs continuous pulse oximetry using an oxygen saturation target of 90%

235 ry 4 hours, n = 114) or continuous (n = 115) pulse oximetry, using an oxygen saturation target of 90%

236 Minimal pulse oximetry value during endotracheal intubation was

237 actors independently associated with minimal pulse oximetry value were the Simplified Acute Physiolog

238 ociations between preoxygenation devices and pulse oximetry values during endotracheal intubation.

239 ients were significantly more likely to have pulse oximetry values that masked an indication for COVI

240 rstood and routinely assessed in patients by pulse oximetry, variability at the single-cell level has

241 Is) were recorded, and relationships between pulse oximetry variables and survival were analyzed.

242 With the exception of pulse oximetry vital sign days, the readings in most vit

243 Sensitivity of pulse oximetry was 75.00% (95% CI 53.29-90.23) for criti

244 itical congenital heart disease (CCHD) using pulse oximetry was added to the recommended uniform scre

245 rt defects was particularly low when newborn pulse oximetry was done after 24 h from birth than when

246 n administration, monitoring with continuous pulse oximetry was frequent and varied widely among hosp

247 thetic inhibition.Oxyhaemoglobin saturation (pulse oximetry) was decreased (P<0.001) with hypoxia (63

248 The primary outcome, receipt of continuous pulse oximetry, was measured using direct observation.

249 To estimate availability of pulse oximetry, we sent surveys to anaesthesia providers

250 Electrocardiography telemetry and pulse oximetry were monitored continuously, and live con

251 ), Lake Louise AMS score, and Sao2 level (by pulse oximetry) were measured.

252 theatres and quantified the availability of pulse oximetry, which is an essential monitoring device

253 Oxygen saturation was monitored by pulse oximetry, which recorded the number of times satur

254 Oxygen saturation (SaO2) was measured by pulse oximetry while children were awake and asleep.

255 ng phase contrast angiography and pre-ductal pulse oximetry, while regional cerebral oxygen saturatio

256 It is imperative to validate pulse oximetry with expanded racial inclusion.

257 We also found that the combination of pulse oximetry with integrated management of childhood i